[Use of the reduction indicator triphenyltetrazolium chloride in examination of the conduction system].
D001145:Arrhythmias, Cardiac; D053840:Brugada Syndrome; D000075224:Cardiac Conduction System Disease; D004396:Coloring Agents; D006321:Heart / Q000294:innervation*; D006329:Heart Conduction System; D006801:Humans; D013194:Staining and Labeling; D013778:Tetrazolium Salts
D004396:Coloring Agents; D013778:Tetrazolium Salts; C009591:triphenyltetrazolium
HEART/innervation; STAINS AND STAINING
Uber die Anwendung des Reduktionsindikators Triphenyltetrazoliumchlorid (TTC) bei Untersuchungen am Reizleitungssystem (RLS).